
Aurantiamide
CAS No. 58115-31-4
Aurantiamide( TMC-58B )
Catalog No. M20469 CAS No. 58115-31-4
Aurantiamide has anti-cancer anti-inflammatory and antinociceptive activities it may suppress the growth of malignant gliomas by blocking autophagic flux.Aurantiamide has an anti-neuroinflammatory effect on LPS stimulation through its inhibition of the NF-κB JNK and p38 pathways.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 374 | In Stock |
![]() ![]() |
10MG | 556 | In Stock |
![]() ![]() |
25MG | 887 | In Stock |
![]() ![]() |
50MG | 1197 | In Stock |
![]() ![]() |
100MG | 1611 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAurantiamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAurantiamide has anti-cancer anti-inflammatory and antinociceptive activities it may suppress the growth of malignant gliomas by blocking autophagic flux.Aurantiamide has an anti-neuroinflammatory effect on LPS stimulation through its inhibition of the NF-κB JNK and p38 pathways.
-
DescriptionAurantiamide has anti-cancer anti-inflammatory and antinociceptive activities it may suppress the growth of malignant gliomas by blocking autophagic flux.Aurantiamide has an anti-neuroinflammatory effect on LPS stimulation through its inhibition of the NF-κB JNK and p38 pathways.
-
In Vitro——
-
In Vivo——
-
SynonymsTMC-58B
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB|p38
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number58115-31-4
-
Formula Weight402.5
-
Molecular FormulaC25H26N2O3?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
CL075
CL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering the MyD88-dependent signaling pathway and activating NF-κB and IRF7 to elicit the production of inflammatory cytokines and type I interferon (IFN).
-
Urolithin B
Urolithin B inhibits NF-κB activity by reducing the phosphorylation and degradation of IκBα, and suppresses the phosphorylation of JNK, ERK, and Akt, and enhances the phosphorylation of AMPK.?Urolithin B is also a regulator of skeletal muscle mass.Urolithin B is one of the gut microbial metabolites of ellagitannins, and has anti-inflammatory and antioxidant effects.
-
Methylene Blue
Methylene Blue(IC50 of 1.9 μM) inhibits tau filament formation. And it inhibits soluble guanylyl cyclase. It is also used as a dye in chromoendoscopy.